Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

<< Previous

Bullboard Posts

Next >>

Post by saintpeteron Jul 23, 2021 10:41pm

137 Views

Post# 33600305

todays trades

House Positions for C:VXL from 20210723 to 20210723

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
85 Scotia	50,100	4,258	0.085	2	0	0.00	50,098	-4,258
7 TD Sec	11,806	992	0.084	2,606	214	0.082	9,200	-778
80 National Bank	14,500	1,232	0.085	10,500	877	0.084	4,000	-355
212 Virtu	2	0	0.00	100	8	0.08	-98	8
68 Leede	0			500	42	0.084	-500	42
79 CIBC	0			4,700	376	0.08	-4,700	376
19 Desjardins	0			5,000	400	0.08	-5,000	400
1 Anonymous	5,000	400	0.08	12,000	1,020	0.085	-7,000	620
33 Canaccord	7,000	560	0.08	53,000	4,505	0.085	-46,000	3,945
TOTAL	88,408	7,442	0.084	88,408	7,442	0.084	0	0